Updated
Abbott LaboratoriesABT · Healthcare
$110.53+0.52%
Market cap$191.4B
IndustryMedical Devices
Abbott Laboratories (ABT) Superinvestor holders
41 of the superinvestors we track hold Abbott Laboratories (ABT) in their latest 13F filings, $5.6B in total.
Summary
The largest holder is Arrowstreet Capital, with $989M, 0.4% of the portfolio.
In their latest quarter: 3 opened a new position, 13 added, 18 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Arrowstreet Capital | Added | 10,897,178 | $989M | 0.4% | Q2 2026 |
| Jeremy Grantham GMO |
Trimmed | 8,794,077 | $798M | 1.8% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 8,126,315 | $737M | 0.6% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 5,542,438 | $503M | 0.4% | Q2 2026 |
| Ric Dillon Diamond Hill Capital Management |
Trimmed | 4,936,774 | $448M | 3.6% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 4,193,058 | $380M | 0.1% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Trimmed | 3,278,314 | $297M | 0.7% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Added | 2,490,670 | $226M | 0.5% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 2,381,366 | $216M | 0.4% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 1,551,929 | $141M | 0.2% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 1,457,592 | $132M | 0.1% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 916,836 | $91M | 0.1% | Q3 2026 |
| Jensen Investment Management | Trimmed | 885,262 | $80M | 1.9% | Q2 2026 |
| Mason Hawkins Southeastern Asset Management |
New position | 840,747 | $76M | 4.0% | Q2 2026 |
| Man Group Man Group plc |
Added | 800,719 | $73M | 0.1% | Q2 2026 |
| PRIMECAP Management PRIMECAP Management Co |
Trimmed | 761,900 | $69M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 730,332 | $66M | 0.3% | Q2 2026 |
| Mairs & Power Mairs & Power Inc |
Added | 729,358 | $66M | 0.6% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 686,366 | $62M | 0.1% | Q2 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 467,019 | $46M | 0.0% | Q3 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 490,181 | $44M | 0.1% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 107,475 | $10M | 0.0% | Q2 2026 |
| Alan Breed Edgewood Management |
Held | 68,016 | $6M | 0.1% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 59,775 | $5M | 0.0% | Q2 2026 |
| David Katz Matrix Asset Advisors |
Added | 52,805 | $5M | 0.4% | Q3 2026 |
| Howard Gleicher Aristotle Capital Management |
Trimmed | 53,857 | $5M | 0.0% | Q2 2026 |
| Neil Hennessy Hennessy Advisors |
Held | 48,500 | $5M | 0.2% | Q3 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 50,140 | $5M | 0.0% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 46,925 | $4M | 0.1% | Q2 2026 |
| George Soros Soros Fund Management |
Held | 44,750 | $4M | 0.1% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Trimmed | 21,671 | $2M | 0.0% | Q2 2026 |
| Eric Marshall Hodges Capital Management |
New position | 20,916 | $2M | 0.1% | Q2 2026 |
| Dodge & Cox | Held | 17,324 | $2M | 0.0% | Q2 2026 |
| Tom Russo Gardner Russo & Quinn |
Held | 11,510 | $1M | 0.0% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Added | 9,716 | $881,630 | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Trimmed | 8,416 | $763,668 | 0.0% | Q2 2026 |
| Mark Donovan Boston Partners |
Trimmed | 8,338 | $755,963 | 0.0% | Q2 2026 |
| Josef Lakonishok LSV Asset Management |
Held | 3,225 | $319,000 | 0.0% | Q3 2026 |
| Dan Davidowitz Polen Capital Management |
Trimmed | 3,156 | $286,379 | 0.0% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Added | 1,506 | $136,693 | 0.0% | Q2 2026 |
| Will Nasgovitz Heartland Advisors |
Held | 1,350 | $122,499 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 41 |
| Q1 2026 | 42 |
| Q4 2025 | 39 |
| Q3 2025 | 36 |
| Q2 2025 | 37 |
| Q1 2025 | 38 |
| Q4 2024 | 36 |
| Q3 2024 | 42 |
Questions about Abbott Laboratories
Which superinvestors own Abbott Laboratories?
41 of the superinvestors we track hold Abbott Laboratories (ABT) in their latest 13F filings, $5.6B in total. Arrowstreet Capital, Jeremy Grantham, Two Sigma, Paul Marshall, Ric Dillon, Cliff Asness.
Who is the largest superinvestor holder of ABT?
The largest holder is Arrowstreet Capital, with $989M, 0.4% of the portfolio.
From Abbott Laboratories's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.